greeksoup/ stock research
Stock research / United States / AMRX / Planned sales

Amneal Pharmaceuticals, Inc. planned insider sales

In the last twelve months insiders at Amneal Pharmaceuticals, Inc. filed 7 Form 144 notices of planned sales, 791,651 shares worth $12.6 million at the time of filing, from 6 sellers. The latest, filed 13 August 2026: John Kiely (director), 50,000 shares worth $879,714, planned for around 13 August 2026 through MERRILL LYNCH.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
13 August 2026John KielyDirector50,000$879,71413 August 202650,000 shares from 13 August 2026MERRILL LYNCHEQUITY COMPENSATIONForm 144
12 August 2026Nikita ShahOfficer146,403$2.6 million12 August 2026146,403 shares from 12 August 2026MERRILL LYNCHEQUITY COMPENSATIONForm 144
12 August 2026Jason DalyOfficer210,000$3.6 million11 August 2026216,613 shares from 11 August 2026MERRILL LYNCHEQUITY COMPENSATIONForm 144
11 August 2026Buchi J KevinDirector168,573$2.9 million11 August 2026None on Form 4 yetCharles Schwab CorpRestricted Stock AwardForm 144
11 May 2026Deborah AutorDirector34,819$450,41611 May 202634,819 shares from 11 May 2026MERRILL LYNCHEQUITY COMPENSATIONForm 144
17 November 2025Nark Ted CDirector50,000$591,25017 November 202550,000 shares from 17 November 2025Charles Schwab Corp.Open Market PurchaseForm 144
12 November 2025Nikita ShahOfficer131,856$1.6 million12 November 2025131,856 shares from 12 November 2025MERRILL LYNCHSTOCK OPTION EXERCISEForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?